Cochlear Implantation in Children with Enlarged Vestibular Aqueduct: A Systematic Review of Surgical Implications and

Marie-Louise Uhre Hansen1,2, Eva Rye Rasmussen3, Per Cayé-Thomasen1

  • 1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology Rigshospitalet, Denmark.

Ear and Hearing
|November 18, 2022
PubMed

Insights

Cochlear implantation significantly improves hearing and speech in children with Pendred Syndrome (PS) or non-syndromic enlarged vestibular aqueduct (NSEVA). While implantation ages have decreased, they remain higher than in the general pediatric population, with perilymph gusher/oozing being the most common complication.

Area of Science:

  • Otolaryngology
  • Pediatric audiology
  • Genetics

Background:

  • Pendred Syndrome (PS) and non-syndromic enlarged vestibular aqueduct (NSEVA) are genetic conditions causing hearing loss in children.
  • Cochlear implantation is a common intervention for pediatric hearing loss, but outcomes in PS/NSEVA require specific evaluation.

Approach:

  • A systematic review of studies published between 1984 and 2021 was conducted.
  • 55 studies were analyzed, focusing on pediatric cochlear implant recipients with PS or NSEVA.
  • Data on age at implantation, audiological outcomes, speech perception, and surgical complications were extracted and assessed.

Key Points:

  • Cochlear implantation improved the four-frequency pure-tone audiogram average by 60–78 dB HL.
  • Auditory performance and speech intelligibility scores increased by an average of 44%.
  • The average age of implantation decreased by 21 months in studies post-2000 compared to earlier studies, with an overall average of 60 months.
  • Perilymph gusher/oozing was the most frequent surgical complication, reported in 187 of 1572 implantations.

Conclusions:

  • Cochlear implantation offers significant audiological and speech benefits for children with PS/NSEVA.
  • Despite a trend towards earlier implantation, the average age remains higher than for unselected pediatric cases.
  • Understanding surgical complication rates, particularly perilymph gusher/oozing, is crucial for managing these patients.
Abstract